MedTrace Logo

Transplantation of Fibroblast for Correction of Nasolabial Folds

NCT03140319 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-10-27

No results posted yet for this study

Summary

The study evaluated the safety and efficacy of the Autologous cultured fibroblast for correction of Nasolabial folds and inhibition of skin aging

Conditions

  • Nasolabial Folds
  • Skin Aging

Interventions

BIOLOGICAL

Fibroblast

Transplantation of 20 million cell by three injection

BIOLOGICAL

Placebo

Injection of Placebo

Sponsors & Collaborators

  • SCARM Institute, Tabriz, Iran

    lead OTHER_GOV

Principal Investigators

  • Peyman Keyhanvar, MD, Ph.D · Deputy for translational medicine of SCARM institute

  • Mohammad Nouri, Ph.D · Head of SCARM institute

  • Raheleh Farahzadi, Ph.D · cardiovascular research center, Tabriz University of Medical Sciences, Tabriz, Iran

  • Samira Asghari, MSc · SCARM institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-10
Primary Completion
2021-11-15
Completion
2021-12-26

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140319 on ClinicalTrials.gov